DeepSeek's Cost Bet Turns to Capital: V4.1-Flash, an In-House Chip, and the Road to IPO AI & Infrastructure September 19, 2026
HexemBio's $15.5M Bet: Rejuvenating Blood Stem Cells in a Synthetic Yolk Sac Biotech & Health September 18, 2026